ATEYY vs. CRVS

Last updated Jun 9, 2026

ATEYY (Advantest Corp DRC) and CRVS (Corvus Pharmaceuticals, Inc.) are both stocks. ATEYY operates in Semiconductor Equipment & Materials (Technology), while CRVS operates in Biotechnology (Healthcare). Over the past 10 years, ATEYY returned 51.21%/yr vs -1.39%/yr for CRVS. At a 0.16 correlation, their price movements are largely independent.

Performance

ATEYY vs. CRVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Advantest Corp DRC (ATEYY) and Corvus Pharmaceuticals, Inc. (CRVS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ATEYY achieves a 31.02% return, which is significantly lower than CRVS's 44.81% return. Over the past 10 years, ATEYY has outperformed CRVS with an annualized return of 51.21%, while CRVS has yielded a comparatively lower -1.39% annualized return.

ATEYY

• 1D: 7.82%
• 1M: -16.54%
• YTD: 31.02%
• 6M: 27.11%
• 1Y: 199.81%
• 3Y*: 73.30%
• 5Y*: 49.34%
• 10Y*: 51.21%

CRVS

• 1D: 0.27%
• 1M: -28.30%
• YTD: 44.81%
• 6M: 30.26%
• 1Y: 185.17%
• 3Y*: 46.04%
• 5Y*: 31.93%
• 10Y*: -1.39%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ATEYY vs. CRVS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ATEYY Advantest Corp DRC	31.02%	122.70%	68.99%	111.43%	-33.43%	27.37%	30.96%	176.84%	12.51%	12.66%
CRVS Corvus Pharmaceuticals, Inc.	44.81%	43.93%	203.98%	107.06%	-64.73%	-32.30%	-34.56%	48.23%	-64.58%	-27.55%

Correlation

The correlation between ATEYY and CRVS is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.27
Correlation (3Y) Calculated over the trailing 3-year period	0.20
Correlation (5Y) Calculated over the trailing 5-year period	0.22
Correlation (10Y) Calculated over the trailing 10-year period	0.16
Correlation (All Time) Calculated using the full available price history since Mar 24, 2016	0.16

The correlation between ATEYY and CRVS shifts across timeframes, from 0.16 (all time) to 0.27 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ATEYY : $120.75B CRVS : $1.00B
EPS ATEYY : $520.21 CRVS : -$0.53
PB Ratio ATEYY : 0.15 CRVS : 4.17
Total Revenue (TTM) ATEYY : $1.14T CRVS : $0.00
Gross Profit (TTM) ATEYY : $736.09B CRVS : -$26.00K
EBITDA (TTM) ATEYY : $533.69B CRVS : -$47.43M

Return for Risk

ATEYY vs. CRVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ATEYY

ATEYY Risk / Return Rank: 92
ATEYY Sharpe Ratio Rank: 95
ATEYY Sortino Ratio Rank: 91
ATEYY Omega Ratio Rank: 89
ATEYY Calmar Ratio Rank: 94
ATEYY Martin Ratio Rank: 94

CRVS

CRVS Risk / Return Rank: 86
CRVS Sharpe Ratio Rank: 74
CRVS Sortino Ratio Rank: 96
CRVS Omega Ratio Rank: 93
CRVS Calmar Ratio Rank: 85
CRVS Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ATEYY vs. CRVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Advantest Corp DRC (ATEYY) and Corvus Pharmaceuticals, Inc. (CRVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ATEYY	CRVS	Difference
Sharpe ratio: Return per unit of total volatility	2.96	1.03	+1.93
Sortino ratio: Return per unit of downside risk	3.19	4.25	-1.05
Omega ratio: Gain probability vs. loss probability	1.39	1.48	-0.08
Calmar ratio: Return relative to maximum drawdown	6.05	3.30	+2.75
Martin ratio: Return relative to average drawdown	16.62	7.42	+9.20
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ATEYY vs. CRVS - Sharpe Ratio Comparison

The current ATEYY Sharpe Ratio is 2.96, which is higher than the CRVS Sharpe Ratio of 1.03. The chart below compares the historical Sharpe Ratios of ATEYY and CRVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ATEYY	CRVS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.96	1.03	+1.93
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.94	0.24	+0.70
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	1.07	-0.01	+1.08
Sharpe Ratio (All Time) Calculated using the full available price history	1.13	-0.02	+1.15

Drawdowns

ATEYY vs. CRVS - Drawdown Comparison

The maximum ATEYY drawdown since its inception was -56.48%, smaller than the maximum CRVS drawdown of -96.97%. Use the drawdown chart below to compare losses from any high point for ATEYY and CRVS.

Drawdown Indicators

	ATEYY	CRVS	Difference
Max Drawdown Largest peak-to-trough decline	-56.48%	-96.97%	+40.49%
Max Drawdown (1Y) Largest decline over 1 year	-33.24%	-56.43%	+23.19%
Max Drawdown (3Y) Largest decline over 3 years	-44.70%	-70.50%	+25.80%
Max Drawdown (5Y) Largest decline over 5 years	-56.48%	-92.40%	+35.92%
Max Drawdown (10Y) Largest decline over 10 years	-56.48%	-96.97%	+40.49%
Current Drawdown Current decline from peak	-16.54%	-56.31%	+39.77%
Average Drawdown Average peak-to-trough decline	-14.23%	-69.32%	+55.09%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.08%	25.07%	-12.99%

Volatility

ATEYY vs. CRVS - Volatility Comparison

The current volatility for Advantest Corp DRC (ATEYY) is 21.85%, while Corvus Pharmaceuticals, Inc. (CRVS) has a volatility of 23.70%. This indicates that ATEYY experiences smaller price fluctuations and is considered to be less risky than CRVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ATEYY	CRVS	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.85%	23.70%	-1.85%
Volatility (6M) Calculated over the trailing 6-month period	51.89%	111.87%	-59.98%
Volatility (1Y) Calculated over the trailing 1-year period	68.01%	181.10%	-113.09%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	52.61%	131.06%	-78.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	48.23%	111.16%	-62.93%

Dividends

ATEYY vs. CRVS - Dividend Comparison

Neither ATEYY nor CRVS has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
ATEYY Advantest Corp DRC	0.00%	0.11%	0.22%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.18%	1.24%
CRVS Corvus Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both ATEYY and CRVS in my portfolio?

ATEYY and CRVS have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ATEYY or CRVS?

CRVS has higher volatility (23.70%) compared to ATEYY (21.85%). In terms of maximum drawdown, ATEYY dropped -56.48% vs CRVS's -96.97%.

Which has better risk-adjusted returns?

ATEYY currently has the higher Sharpe Ratio (2.96 vs 1.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.